Clinical Trial 55679

Los Angeles, CA 90010


Summary:

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.


Qualified Participants Must:

• 18 years and older
• Chronic kidney disease Stage 3-4
• History of Heart attack
• History of stroke
• Prior angioplasty
• Bypass surgery
• Peripheral Artery Disease


Qualified Participants May Receive:

Stipend - $50/visit (20 visits)

Free Uber transport roundtrip


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.